WASHINGTON (dpa-AFX) - While reporting financial results for the second quarter on Thursday, biopharmaceutical company AbbVie, Inc. (ABBV) raised its adjusted earnings guidance for the full-year 2024.
For fiscal 2024, AbbVie now projects adjusted earnings in a range of $10.71 to $10.91 per share, which includes an unfavorable impact of $0.60 per share related to acquired IPR&D and milestones expense incurred year-to-date through the second quarter 2024.
However, the adjusted earnings guidance excludes any impact from acquired IPR&D and milestones that may be incurred beyond the second quarter of 2024, as both cannot be reliably forecasted.
Previously, the company expected adjusted earnings in the range of $10.61 to $10.81 per share.
On average, 20 analysts polled by Thomson Reuters expect the company to report earnings of $9.93 per share for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2024 AFX News
